Ann Indian Acad Neurol. 2015 Jul-Sep;18(3):309-13. doi: 10.4103/0972-2327.160102.

Serial macro-architectural alterations with levodopa in Parkinson's disease: Polysomnography (PSG)-based analysis.

Annals of Indian Academy of Neurology

Sanju P Joy, Sanjib Sinha, Pramod Kumar Pal, Samhita Panda, M Philip, Arun B Taly

PMID: 26425009 PMCID: PMC4564466 DOI: 10.4103/0972-2327.160102

Abstract

PURPOSE: We studied the sleep macroarchitecture with polysomnography (PSG) in drug naïve patients with Parkinson's disease (PD) and reassessed them following treatment with levodopa.

MATERIALS AND METHODS: This prospective hospital-based study included 15 patients with PD (age: 59 ± 11.2 years, duration of PD: 11.8 ± 12.3 months; and male: female (M:F) = 11:4). They were assessed for demography, phenotype, modified Hoehn and Yahr staging (H & Y); Schwab and England and Activities of Daily Living (S and E ADL) Scale; and Unified PDRating Scale (UPDRS). Sleep was assessed using Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and National Institute of Mental Health and Neurosciences (NIMHANS) comprehensive sleep disorder questionnaire. They underwent overnight PSG at baseline and after13.3 ± 5.7 months of levodopa (440 mg/day).

RESULTS: Patients with PD had responded to levodopa as indicated by the significant improvement in UPDRS motor score in ON state compared to OFF state. Nocturnal sleep quality indices did not vary significantly, but the excessive daytime somnolence improved (P = 0.04) with levodopa. Sleep efficiency (P = 0.65), latency to sleep onset (P = 0.19), latency to stage 1 (P = 0.12), and duration of stage 1 (P = 0.55) had increased. Duration of 'awake in bed' (P = 0.24), slow wave sleep (P = 0.29), and rapid eye movement (REM) sleep (P = 0.24) decreased with treatment. Periodic leg movements (PLMs) had reduced (P = 0.68) and mean oxygen saturation during sleep improved (P = 0.002). Surprisingly, snore index (P < 0.03) during sleep had increased with levodopa.

CONCLUSIONS: Sleep alterations in PD occur even in early stages due to the disease process. There was improvement in most of the parameters of sleep macroarchitecture with levodopa.

Keywords: Levodopa; Parkinson's disease; polysomnography; sleep

References

1. Sleep. 1991 Dec;14(6):540-5 - PubMed
2. Mov Disord. 2008 Jan;23(1):35-41 - PubMed
3. Parkinsonism Relat Disord. 2004 Mar;10(3):157-68 - PubMed
4. Mov Disord. 2003 Jun;18(6):659-67 - PubMed
5. Mov Disord. 2005 Nov;20(11):1413-8 - PubMed
6. Sleep Med. 2006 Jun;7(4):333-9 - PubMed
7. Neurology. 2002 Feb 12;58(3):341-6 - PubMed
8. Mov Disord. 2003 May;18(5):467-86 - PubMed
9. Sleep. 2002 Aug 1;25(5):573-7 - PubMed
10. J Neurol. 1998 May;245 Suppl 1:S15-8 - PubMed
11. Mov Disord. 2002 Jul;17(4):775-81 - PubMed
12. Sleep Med. 2003 Jul;4(4):275-80 - PubMed
13. Mov Disord. 2002 Sep;17(5):1026-30 - PubMed
14. Brain. 2002 Apr;125(Pt 4):861-70 - PubMed
15. Sleep Med. 2003 Jul;4(4):339-42 - PubMed
16. J Neurol Sci. 2006 Oct 25;248(1-2):158-62 - PubMed
17. Nat Sci Sleep. 2011 Dec 01;3:125-33 - PubMed
18. Mov Disord. 2009 Dec 15;24(16):2419-23 - PubMed
19. JAMA. 2002 Jan 23-30;287(4):455-63 - PubMed
20. Sleep Med Rev. 2011 Feb;15(1):41-50 - PubMed
21. Mov Disord. 2010;25 Suppl 1:S117-22 - PubMed
22. Neurol India. 2012 Jan-Feb;60(1):68-74 - PubMed
23. Acta Neurol Belg. 1975 Jan-Feb;75(1):5-10 - PubMed
24. Eur J Neurol. 2005 Mar;12(3):199-207 - PubMed
25. Singapore Med J. 2010 Jan;51(1):60-4 - PubMed
26. Respir Med. 2003 Oct;97(10):1151-7 - PubMed
27. Mov Disord. 1998 Nov;13(6):895-9 - PubMed
28. J Neurol. 2005 Aug;252(8):936-43 - PubMed
29. Mov Disord. 2001 Sep;16(5):928-33 - PubMed
30. Mov Disord. 1990;5(4):280-5 - PubMed
31. Ann Indian Acad Neurol. 2014 Jul;17(3):287-91 - PubMed
32. Psychiatry Res. 1989 May;28(2):193-213 - PubMed
33. J Neurol Sci. 2006 Dec 1;250(1-2):39-44 - PubMed
34. Arch Neurol. 2002 Mar;59(3):421-4 - PubMed
35. Sleep. 2000 May 1;23(3):361-7 - PubMed

Publication Types

• Journal Article